Sangamo Therapeutics, Inc. Profile Avatar - Palmy Investing

Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The…

Biotechnology
US, Brisbane California [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Sangamo Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Sangamo Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Sangamo Therapeutics, Inc..

End of SGMO's Analysis
CIK: 1001233 CUSIP: 800677106 ISIN: US8006771062 LEI: - UEI: -
Secondary Listings